⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AQST News
Aquestive Therapeutics, Inc. Common Stock
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AQST
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
Pomerantz LLP Alerts Shareholders to Investor Suit Against Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST
accessnewswire.com
AQST
AQST SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 Ready to Announce with Confidence?
newsfilecorp.com
AQST
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AQST
Pomerantz LLP Alerts Shareholders to Investor Suit Against Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
Pomerantz LLP Advises Shareholders of Class Action Involving Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST
accessnewswire.com
AQST